期刊文献+

水难溶性药物的载体材料研究进展 被引量:7

Research Progresses of Carrier Materials for Water-insoluable Drugs
下载PDF
导出
摘要 水难溶性药物因其在水中溶解度小使得药物的临床应用受到限制。将水难溶性药物通过某些载体包裹,是对水难溶性药物进行增溶的一种行之有效的方法。综述了水难溶性药物载体材料的研究进展,并总结了各种载体材料的优缺点。针对普遍存在的增溶效果不理想的问题,指出了几种载体未来的发展方向。表面活性剂胶束因其自身的毒性而逐渐被其它载体材料取代。环糊精和聚合物胶束具有广阔的发展前景。尽管脂质体作为水难溶性药物载体存在不足之处,但其可用作水溶性药物的载体或者制备成主动靶向制剂(例如单克隆抗体导向的脂质体)、物理化学靶向制剂(例如磁靶向脂质体),仍具有巨大的研究价值和发展空间。 Clinical applications of water-insoluble drugs are limited for their poor solubilities. It's an effective approach to enhance the solubility via coating these water-insoluble drugs by some carrier materials. In this paper, re- cent research progresses of several carrier materials for water-insoluble drugs are reviewed, and advantage and disad- vantage corresponding to each carrier materials are summarized. For the ubiquitous problem of unsatisfactory solubili- zing effect, the development trend and prospects of these carrier materials are proposed. Surface active agent micelle will be substituted by other carrier materials for its toxicity. Cyclodextrin and polymeric micelle have vast potential for future development. Although the deficiencies in encapsulating water-insoluable drugs, liposome can be used as carrier for soluble drugs or to prepare active targeting preparation (e. g. monoclonal antibody oriented liposome) and physical- chemical targeting preparation (e. g. magnetic liposome). Therefore, liposome still has great research value and development potential.
出处 《材料导报》 EI CAS CSCD 北大核心 2010年第9期67-70,共4页 Materials Reports
基金 陕西省自然科学基金(2009JQ2013) 西北工业大学科技创新基金(2008KJ02041)
关键词 水难溶性药物 载体 脂质体 环糊精 胶束 water-insoluble drugs, carrier, liposome, cyclodextrin, micelle
  • 相关文献

参考文献30

  • 1Verreck G,Chun I,Peeters J,et al.Preparation and cha-racterization of nanofibers containing amorphous drug dis-persions generated by electrostatic spinning[J].Pharm Ras,2003,20(5):810.
  • 2Perrut M,Jung J,Leboeuf F.Enhancement of dissolution rate of poorly-soluble active ingredients by supercrifical fluid processes Part I:Micronization of neat articles[J].Int J Pharrn,2005,288(1):3.
  • 3张子豫,贾丽君,龚建刚,李广宙,康白.紫杉醇长循环脂质体的制备及其药动学研究[J].食品与药品,2009,11(1):14-17. 被引量:11
  • 4Sharma U S,Balasubramanian S V,et al.Pharmaceutical and physical properties of paclitaxel(taxel)complexes with cyclodextrins[J].J Pharm Sci,1995,84(10):1210.
  • 5周卫,平其能,王丽杰.羟喜树碱脂质体的粒径对组织分布的影响[J].中国药科大学学报,2005,36(2):125-128. 被引量:15
  • 6Watanabe M,Kawano K,Toma K,et al.In vivo antitumor activity of camptothecin incorporated in liposomes formula-ted with an artificial lipid and human serum albumin[J].J Control Rel,2008,127:231.
  • 7宋金春,黄岭,陈佳丽.羟基喜树碱脂质体的制备及其包封率测定[J].中国医院药学杂志,2007,27(10):1381-1383. 被引量:10
  • 8赵若威,王强,刘立恒,樊荣.尼莫地平纳米脂质体制备工艺及处方优化研究[J].黑龙江医学,2006,30(11):817-820. 被引量:7
  • 9Knight V,Koshkina N V,Waldrep J C,et al.Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xeno-grafts in nude mice[J].Cancer Chemother Pharmacol,1999,44:177.
  • 10Kumaresh S S,Tejraj M A,Anandrao R K,et al.Biode-gradable polymeric nanoparticles as drug delivery devices[J].J Control Rel,2001,70:1.

二级参考文献130

共引文献174

同被引文献86

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部